Histolix Funding Round

6/30/2023

Venture Equity

$3,200,000

Undisclosed

The company intends to use the funds for further evaluation of its Giga Fluorescence Imitating Brightfield Imaging (FIBI).

Private & Independent

Healthcare Services

2700 Stockton Blvd
Sacramento, CA 95817
USA

Histolix has developed a novel point-of-care histopathology solution enabling direct to digital diagnosis of tissue in surgery suites and at the clinical point-of-care, delivering high quality digitized images to permit rapid diagnosis. This can eliminate the need for time consuming and expensive histologic procedure required to produce paraffin sections on glass slides. It could enable same-day patient diagnosis and potentially reduce the requirement of additional surgical procedures, providing direct-to-digital image, slide free pathology designed to be created within five minutes of tissue presentation versus the traditional eight hours to days of required processing for whole slide imaging.